[Asia Economy Reporter Jang Hyowon] SL Bionics announced on the 15th that the agenda items proposed at the extraordinary general meeting of shareholders held on the 9th floor of Leader's Tower in Yongin-si, Gyeonggi-do were approved as originally proposed.
The proposed agenda items included two items: a capital reduction to cover accumulated losses and improve the financial structure, and the addition of business objectives for entering the bio business.
Out of a total of 42,063,813 issued shares, 42,062,068 shares have voting rights. The number of shares that participated in the meeting and exercised voting rights was 18,147,441 shares, accounting for 43.1% of the total shares with voting rights. The approved agenda items received about 38% approval of the total shares with voting rights (electronic voting approval: 11,987,990 shares, opposition: 1,759,656 shares), meeting all the requirements for special resolution approval.
A representative of SL Bionics said, "The agenda items were approved as originally proposed with the full support of the shareholders for decisions regarding the company's future and development," and added, "We will do our best to enhance shareholder value and promote corporate growth for the shareholders who supported us."
Meanwhile, SL Bionics acquired Lumens' Yongin factory, which is considered a key transportation hub in Yongin, for 41.75 billion KRW to increase sales growth and profitability.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
